| 1 |
34432302 | Para-aminosalicylic acid significantly reduced tenofovir exposure in human subjects: Mismatched findings from in vitro to in vivo translational research. | 2022 Mar |
1 |
| 2 |
29720497 | Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity. | 2018 Jul |
4 |
| 3 |
29980578 | Recellularized Native Kidney Scaffolds as a Novel Tool in Nephrotoxicity Screening. | 2018 Sep |
2 |
| 4 |
26821801 | A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity. | 2016 Mar |
1 |
| 5 |
25448811 | Intracellular concentrations determine the cytotoxicity of adefovir, cidofovir and tenofovir. | 2015 Feb |
1 |
| 6 |
24343710 | Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV prevention. | 2014 May |
2 |
| 7 |
24699134 | Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity. | 2014 |
5 |
| 8 |
23896476 | Evaluation of the effect of cobicistat on the in vitro renal transport and cytotoxicity potential of tenofovir. | 2013 Oct |
1 |
| 9 |
21078936 | Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir. | 2011 Feb |
2 |
| 10 |
21403643 | Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters. | 2011 Jun |
5 |
| 11 |
17372702 | Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2). | 2007 Apr |
2 |
| 12 |
17503669 | Molecular assessment of the potential for renal drug interactions between tenofovir and HIV protease inhibitors. | 2007 |
4 |
| 13 |
17005808 | Mechanism of active renal tubular efflux of tenofovir. | 2006 Oct |
1 |
| 14 |
15914676 | Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). | 2005 Aug |
2 |